-
Is the AI boom another dotcom bubble?
25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
-
Vertex Pharmaceuticals is a rare opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Global investors overlook these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
Opinion -
Is now a good time to invest in VCTs?
Venture capital trusts have turned 30 years old. While VCTs are volatile, could now be the right time to invest?
-
UK smaller companies labelled the “most unloved stocks in the world” – should you invest?
UK small caps could offer enticing opportunities for contrarian investors looking to bag a valuation discount. Should you invest?
-
Prosus to buy Just Eat for €4.1bn as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
-
Nvidia earnings live: AI semiconductor giant beats forecasts
Nvidia’s earnings report caps off a Magnificent 7 earnings season that has seen some big tech stocks suffer in the light of DeepSeek’s emergence
-
Tesla sales plummet 45% in Europe – what does it mean for investors?
Tesla's sales are off to a dismal start in Europe in 2025. Is Elon Musk’s politics to blame and should you sell your Tesla shares?
-
Leading companies cashing in on India’s growth prospects
Opinion Ewan Thompson, manager of the Liontrust India fund, highlights three companies he thinks are well-positioned to generate attractive economic returns
Opinion
